Contacts

Stephan Doom, Solicitor (England & Wales)|LL.M. (Nottingham)

Salary Partner

Read More

Michael Stein

Partner

Read More

Dr. Vinia D. Tepel

Associate

Read More

Claus Goedecke

Partner

Read More

Arno Maria Gotting, M.A., LL.M. (King’s College London)

Salary Partner

Read More

Nils Schulze-Brüggemann

Associate

Read More

Dr. Jan W. Grawe

Salary Partner

Read More

Dr. Sara Thienhaus

Senior Associate

Read More

Svenja-Ariane Maucher

Partner

Read More

Matthias Brenner

Associate

Read More

Dr. Stefan Fröhlich

Salary Partner

Read More

Rudi Hasenberg

Salary Partner

Read More

Dr. Andrea Sautter

Salary Partner

Read More

Irina Rebin

Senior Associate

Read More

Tobias Baus, LL.M., Dipl.-Ing.

Senior Associate

Read More

Dr. Marco Hartmann-Rüppel, Dipl.-Volkswirt

Partner

Read More

Nikolaus Vaerst, LL.M. (LSE)

Senior Associate

Read More
Contacts

Stephan Doom, Solicitor (England & Wales)|LL.M. (Nottingham)

Salary Partner

Read More

Michael Stein

Partner

Read More

Dr. Vinia D. Tepel

Associate

Read More

Claus Goedecke

Partner

Read More

Arno Maria Gotting, M.A., LL.M. (King’s College London)

Salary Partner

Read More

Nils Schulze-Brüggemann

Associate

Read More

Dr. Jan W. Grawe

Salary Partner

Read More

Dr. Sara Thienhaus

Senior Associate

Read More

Svenja-Ariane Maucher

Partner

Read More

Matthias Brenner

Associate

Read More

Dr. Stefan Fröhlich

Salary Partner

Read More

Rudi Hasenberg

Salary Partner

Read More

Dr. Andrea Sautter

Salary Partner

Read More

Irina Rebin

Senior Associate

Read More

Tobias Baus, LL.M., Dipl.-Ing.

Senior Associate

Read More

Dr. Marco Hartmann-Rüppel, Dipl.-Volkswirt

Partner

Read More

Nikolaus Vaerst, LL.M. (LSE)

Senior Associate

Read More

17 June 2022

Taylor Wessing advises Azenta Life Sciences on the acquisition of the Barkey Group

Under the lead of M&A Salary Partner Stephan Doom and M&A Partner Michael Stein, Taylor Wessing has advised US-based Azenta, Inc. (NASDAQ: AZTA) on the acquisition of medical technology company Barkey including all of its subsidiaries. The purchase price is approximately € 80 million. The transaction is expected to close in early July 2022.

Azenta is based in Chelmsford, near Boston/Massachusetts, and is a leading provider of cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.

Barkey, based in Leopoldshöhe near Bielefeld, Germany, has more than four decades of experience in automated thawing of plasma, blood and stem cells and has focused on applications in cell and gene therapy. Barkey's Plasmatherm product is an automated device for thawing cells that is approved by the U.S. Food and Drug Administration (FDA) as a medical device for clinical use.

Taylor Wessing Germany: Lead Stephan Doom (Salary Partner) and Michael Stein (Partner), Dr. Vinia Tepel (Associate, Hamburg), all Corporate/M&A; Claus Goedecke (Partner, Finance), Arno Gotting (Salary Partner), Nils Schulze-Brüggemann (Associate), both Commercial; Dr. Jan Grawe (Salary Partner), Dr. Sara Thienhaus (Associate) both Employment; Svenja-Ariane Maucher (Partner), Matthias Brenner (Associate), both IT; Dr. Stefan Fröhlich (Salary Partner), Henrik Lerchl (Associate) both IP-Law; Rudi Hasenberg (Salary Partner, Tax), Dr. Andrea Sautter (Salary Partner), Irina Rebin (Associate), Tobias Baus (Associate,) all Life Sciences Regulatory, Munich; Dr. Marco Hartmann-Rüppel (Partner, Hamburg), Louisa Nowalder (Associate, Düsseldorf), both Competition, EU & Trade; Nikolaus Vaerst (Senior Associate, Real Estate, Hamburg); all Frankfurt, unless otherwise stated.

 

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Corporate/M&A & capital markets

Bertelsmann Investments acquires pharma tech company EXTEDO with Taylor Wessing

27 February 2024

by multiple authors

Click here to find out more
Corporate/M&A & capital markets

Taylor Wessing advises Mercurius Health on the acquisition of MEDICLIN Robert Janker Klinik

6 November 2023

by multiple authors

Click here to find out more
Corporate/M&A & capital markets

Taylor Wessing advises Formycon on acquisition of biosimilar assets in strategic partnership with ATHOS

31 March 2022

by multiple authors

Click here to find out more